Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BMGL NYSE:CORBF NASDAQ:QIPT NASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$2.00-2.0%$2.14$0.91▼$9.40$36.91MN/A3.77 million shs53,968 shsCORBFGlobal Cord Blood$1.05$1.02$0.25▼$1.75$127.63M-0.692,256 shsN/AQIPTQuipt Home Medical$2.59-1.5%$2.12$1.35▼$3.27$112.52M0.6579,612 shs515,827 shsSERASera Prognostics$3.33+3.1%$2.69$1.37▼$9.13$125.45M1220,827 shs93,244 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group0.00%+2.51%+0.99%-59.92%+203,999,900.00%CORBFGlobal Cord Blood0.00%-34.38%+47.89%+5.00%-30.00%QIPTQuipt Home Medical0.00%+0.77%+13.85%+46.11%-8.04%SERASera Prognostics0.00%+22.35%+19.63%+69.11%-56.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBMGLBasel Medical GroupN/AN/AN/AN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/AQIPTQuipt Home Medical1.8124 of 5 stars2.35.00.00.02.71.70.0SERASera Prognostics0.945 of 5 stars0.04.00.00.02.32.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMGLBasel Medical Group 0.00N/AN/AN/ACORBFGlobal Cord Blood 0.00N/AN/AN/AQIPTQuipt Home Medical 2.50Moderate Buy$3.1521.62% UpsideSERASera Prognostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BMGL, CORBF, SERA, and QIPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/19/2025QIPTQuipt Home MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$1.70 ➝ $2.30(Data available from 9/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMGLBasel Medical Group$10.00M3.69N/AN/AN/A∞CORBFGlobal Cord Blood$196.12M0.65$0.75 per share1.40N/A∞QIPTQuipt Home Medical$238.38M0.47$1.00 per share2.59$2.49 per share1.04SERASera Prognostics$108K1,161.58N/AN/A$1.40 per share2.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMGLBasel Medical GroupN/AN/A0.00∞N/AN/AN/AN/AN/ACORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/AQIPTQuipt Home Medical-$6.76M-$0.24N/AN/AN/A-4.30%-9.78%-4.23%N/ASERASera Prognostics-$32.90M-$0.85N/AN/AN/A-30,306.48%-45.86%-34.31%11/5/2025 (Estimated)Latest BMGL, CORBF, SERA, and QIPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q3 2025QIPTQuipt Home Medical$0.03-$0.07-$0.10-$0.07$80.37 million$58.30 million8/6/2025Q2 2025SERASera Prognostics-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMGLBasel Medical GroupN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/AQIPTQuipt Home MedicalN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMGLBasel Medical GroupN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AQIPTQuipt Home Medical0.711.150.75SERASera PrognosticsN/A1.731.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMGLBasel Medical GroupN/ACORBFGlobal Cord BloodN/AQIPTQuipt Home Medical42.85%SERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipBMGLBasel Medical GroupN/ACORBFGlobal Cord Blood0.50%QIPTQuipt Home Medical13.40%SERASera Prognostics15.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMGLBasel Medical Group3618.46 millionN/AN/ACORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableQIPTQuipt Home Medical1,20043.44 million37.62 millionOptionableSERASera Prognostics12037.67 million31.72 millionOptionableBMGL, CORBF, SERA, and QIPT HeadlinesRecent News About These CompaniesGhisallo Capital Management LLC Makes New $368,000 Investment in Sera Prognostics, Inc. $SERASeptember 2 at 8:33 AM | marketbeat.comSERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCEAugust 28, 2025 | prnewswire.comAberdeen Group plc Invests $4.56 Million in Sera Prognostics, Inc. $SERAAugust 23, 2025 | marketbeat.comRobert Gardner Harrison Sells 6,000 Shares of Sera Prognostics (NASDAQ:SERA) StockAugust 21, 2025 | insidertrades.comSera Prognostics (NASDAQ:SERA) Lowered to Sell Rating by Wall Street ZenAugust 10, 2025 | marketbeat.comSera Prognostics, Inc. (NASDAQ:SERA) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comSera Prognostics outlines European expansion and new commercial hires while targeting PreTRM Test reimbursement pilotsAugust 7, 2025 | msn.comSera Prognostics, Inc. (SERA) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comSera Prognostics (SERA) Q2 Loss Down 4%August 6, 2025 | fool.comSera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue EstimatesAugust 6, 2025 | zacks.comSERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTSAugust 6, 2025 | prnewswire.comSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | prnewswire.comSera Prognostics director Mirza sells $552 in stockJuly 10, 2025 | investing.comSera Prognostics (NASDAQ:SERA) Stock, Insider Trading ActivityJune 30, 2025 | benzinga.comSera Prognostics: PreTRM Labor Test Should Represent Advance In Risk AssessmentJune 30, 2025 | seekingalpha.comSera Prognostics, Inc. (NASDAQ:SERA) CEO Sells $32,950.06 in StockJune 12, 2025 | insidertrades.comWe Think Sera Prognostics (NASDAQ:SERA) Needs To Drive Business Growth CarefullyJune 10, 2025 | finance.yahoo.comsera prognostics announces board elections and auditor ratificationJune 7, 2025 | investing.comAfter Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA)May 29, 2025 | zacks.comSERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESMay 29, 2025 | prnewswire.comSera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2025 Financial ResultsMay 26, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBMGL, CORBF, SERA, and QIPT Company DescriptionsBasel Medical Group NASDAQ:BMGL$2.00 -0.04 (-1.96%) As of 04:00 PM EasternBasel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.Global Cord Blood NYSE:CORBF$1.05 0.00 (0.00%) As of 08/29/2025Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Quipt Home Medical NASDAQ:QIPT$2.59 -0.04 (-1.52%) Closing price 04:00 PM EasternExtended Trading$2.55 -0.04 (-1.51%) As of 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Sera Prognostics NASDAQ:SERA$3.33 +0.10 (+3.10%) Closing price 04:00 PM EasternExtended Trading$3.47 +0.14 (+4.20%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Loop Industries Insiders Buy Stock, Signal Confidence in Outlook Joby Aviation's Pullback: A Gift for Investors Who See the Future Kohl’s Stock Rebound Faces a Showdown With Short Sellers What to Watch for From D-Wave Now That Earnings Are Done 3 High-Yield Stocks Just Supercharged Their Dividends MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Alphabet’s Resurgence: It's Now a Clear Market Leader Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
